XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Note 3 - Revenue (Details Textual)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Sep. 30, 2020
USD ($)
Sep. 30, 2019
USD ($)
Revenue from Contract with Customer, Including Assessed Tax   $ 10,549 $ 0 $ 38,728 $ 0
Manufacturing Revenue [Member]          
Revenue from Contract with Customer, Including Assessed Tax   6,000 0 13,500 0
Clinical Trial Service Revenue [Member]          
Revenue from Contract with Customer, Including Assessed Tax   4,549 $ 0 25,228 $ 0
Janssen [Member] | Manufacturing Revenue [Member]          
Proceeds from Customers $ 4,500 4,500      
Deferred Income, Current   $ 6,000   $ 6,000  
Janssen [Member] | Clinical Trial Service Revenue [Member]          
Transition Services Agreement, Number of Ongoing Clinical Trials Entered Into 2        
Transition Services Agreement, Markup Percentage   30.00%   30.00%  
Revenue from Contract with Customer, Including Assessed Tax   $ 4,500   $ 25,200